FSA
BIIB icon

Franklin Street Advisors’s Biogen BIIB Stock Holding History

Franklin Street Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-830
Closed -$335K – 231
2015
Q2 		$335K Hold
830
– – 0.06% 172
2015
Q1 		$350K Buy
830
+30
+4% +$11.8K 0.06% 164
2014
Q4 		$272K Hold
800
– – 0.05% 173
2014
Q3 		$265K Hold
800
– – 0.05% 203
2014
Q2 		$252K Hold
800
– – 0.05% 208
2014
Q1 		$245K Sell
800
-800
-50% -$254K 0.05% 209
2013
Q4 		$447K Hold
1,600
– – 0.09% 174
2013
Q3 		$385K Hold
1,600
– – 0.09% 176
2013
Q2 		$344K Buy
+1,600
New +$342K 0.08% 194

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Franklin Street Advisors's BIIB Position: Q3 2015 in Review

Franklin Street Advisors sold out of Biogen (BIIB) in Q3 2015, closing a stake of 830 shares — an estimated $335K sold.

Franklin Street Advisors first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $447K in Q4 2013. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Franklin Street Advisors reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Franklin Street Advisors sold 830 Biogen shares in Q3 2015, an estimated $335K.
  • Franklin Street Advisors first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
  • Franklin Street Advisors's Biogen position peaked at $447K in Q4 2013.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Franklin Street Advisors's 13F filing for Q3 2015, filed 9 Oct 2015.